51 – 60 of 68
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study.
(
- Contribution to journal › Article
-
Mark
Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo
(
- Contribution to journal › Article
- 2011
-
Mark
Adsorption of low-density lipoprotein, its oxidation, and subsequent binding of specific recombinant antibodies-an in situ ellipsometric study.
(
- Contribution to journal › Article
-
Mark
Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection
(
- Contribution to journal › Article
- 2010
-
Mark
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells
(
- Contribution to journal › Article
-
Mark
Role of T cells in graft rejection and transplantation tolerance
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Regulatory T cells : hypes and limitations
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.
2007) In Atherosclerosis(
- Contribution to journal › Article
-
Mark
Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.
(
- Contribution to journal › Scientific review
-
Mark
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
(
- Contribution to journal › Article